Fluorouracil News and Research

RSS
Fluorouracil is a drug used to treat symptoms of cancer of the colon, breast, stomach, and pancreas. It is also used in a cream to treat certain skin conditions. Fluorouracil stops cells from making DNA and it may kill cancer cells. It is a type of antimetabolite. Also called 5-fluorouracil and 5-FU.
Chemotherapy causes delayed severe neural damage

Chemotherapy causes delayed severe neural damage

The limits of observational data in determining outcomes from cancer therapy

The limits of observational data in determining outcomes from cancer therapy

Angiotech receives FDA clearance to market 5-Fluorouracil-coated central venous catheter

Angiotech receives FDA clearance to market 5-Fluorouracil-coated central venous catheter

Chemotherapy-induced anemia increases risk of local breast cancer recurrence

Chemotherapy-induced anemia increases risk of local breast cancer recurrence

Postoperative chemotherapy does not improve survival in gastric cancer patients

Postoperative chemotherapy does not improve survival in gastric cancer patients

Chemotherapy with chemoradiation for pancreatic cancer has small survival benefit

Chemotherapy with chemoradiation for pancreatic cancer has small survival benefit

Study may aid pancreatic cancer patients' response to chemo drugs

Study may aid pancreatic cancer patients' response to chemo drugs

Combination targets offer new hope in fight against cancer

Combination targets offer new hope in fight against cancer

Cancer drug Taxotere given the green light to treat head and neck cancer

Cancer drug Taxotere given the green light to treat head and neck cancer

Taxotere (docetaxel) granted FDA approval to treat locally advanced head and neck cancer prior to chemo and surgery

Taxotere (docetaxel) granted FDA approval to treat locally advanced head and neck cancer prior to chemo and surgery

PET scans accurately detect a breast tumor's response to chemotherapy

PET scans accurately detect a breast tumor's response to chemotherapy

Phase II study of TroVax vaccine in patients with metastatic colorectal cancer

Phase II study of TroVax vaccine in patients with metastatic colorectal cancer

Study of therapeutic vaccine shows promise for metastatic colorectal cancer

Study of therapeutic vaccine shows promise for metastatic colorectal cancer

Sequential and combination chemotherapy equally effective in treating advanced colorectal cancer

Sequential and combination chemotherapy equally effective in treating advanced colorectal cancer

Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer

Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer

Fat kills cancer!

Fat kills cancer!

Physiological differences between men and women impact colorectal cancer progression

Physiological differences between men and women impact colorectal cancer progression

New drugs to fight colon and breast cancer

New drugs to fight colon and breast cancer

Cancer Research Technology licenses therapeutic antibodies to Peptech

Cancer Research Technology licenses therapeutic antibodies to Peptech

Viventia Biotech announces results of Proxinium antibody in combinaton with chemotherapy and radiation

Viventia Biotech announces results of Proxinium antibody in combinaton with chemotherapy and radiation